These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24624920)

  • 1. Pharmacogenomics of episodic migraine: time has come for a step forward.
    Viana M; Terrazzino S; Genazzani AA; Grieco GS; Cargnin S; Santorelli FM; Pierelli F; Tassorelli C; Nappi G; Di Lorenzo C
    Pharmacogenomics; 2014 Mar; 15(4):541-9. PubMed ID: 24624920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics and migraine: possible implications.
    Tfelt-Hansen P; Brøsen K
    J Headache Pain; 2008 Feb; 9(1):13-8. PubMed ID: 18217199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of migraine: prospects for pharmacogenomics.
    Rogers KL; Lea RA; Griffiths LR
    Am J Pharmacogenomics; 2003; 3(5):329-43. PubMed ID: 14575521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive treatment of migraine.
    Silberstein SD
    Trends Pharmacol Sci; 2006 Aug; 27(8):410-5. PubMed ID: 16820222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of migraine and pharmacogenomics: some considerations.
    Piane M; Lulli P; Farinelli I; Simeoni S; De Filippis S; Patacchioli FR; Martelletti P
    J Headache Pain; 2007 Dec; 8(6):334-9. PubMed ID: 18058067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in migraine: catching biomarkers for a predictable disease control [corrected].
    Simmaco M; Borro M; Missori S; Martelletti P
    Expert Rev Neurother; 2009 Sep; 9(9):1267-9. PubMed ID: 19769441
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.
    Gentile G; Borro M; Simmaco M; Missori S; Lala N; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):39-47. PubMed ID: 21142809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics: state of the research and perspectives in clinical application.
    Severino G; Chillotti C; Stochino ME; Del Zompo M
    Neurol Sci; 2003 May; 24 Suppl 2():S146-8. PubMed ID: 12811615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic insights into migraine treatment in children.
    Gentile G; Chiossi L; Lionetto L; Martelletti P; Borro M
    Pharmacogenomics; 2014 Aug; 15(11):1539-50. PubMed ID: 25303303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.
    Fernandez F; Colson NJ; Griffiths LR
    Pharmacogenomics; 2007 Jun; 8(6):609-22. PubMed ID: 17559350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hunt for new genes and polymorphisms that can control the response to drugs.
    Sheffield LJ
    Pharmacogenomics; 2002 Sep; 3(5):679-86. PubMed ID: 12223052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human genetic variation and personalized medicine.
    Agrawal S; Khan F
    Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic biomarkers for migraine.
    De Vries B; Haan J; Frants RR; Van den Maagdenberg AM; Ferrari MD
    Headache; 2006; 46(7):1059-68. PubMed ID: 16866710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.
    Abdel-Hamid IA; Andersson KE
    Pharmacogenomics; 2009 Oct; 10(10):1625-44. PubMed ID: 19842936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
    Lazaridis KN
    Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic considerations for migraine therapies.
    Capi M; Gentile G; Lionetto L; Salerno G; Cipolla F; Curto M; Borro M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1161-1167. PubMed ID: 30362834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenomics and the path towards personalized medicine].
    Belloso WH; Redal MA
    Medicina (B Aires); 2010; 70(3):265-74. PubMed ID: 20529779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics: the importance of accurate phenotypes.
    Gurwitz D; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):469-70. PubMed ID: 20350123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HapMap, pharmacogenomics, and the goal of personalized prescribing.
    O'Shaughnessy KM
    Br J Clin Pharmacol; 2006 Jun; 61(6):783-6. PubMed ID: 16722846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.